• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
DA Huijuan,CAO Qiuhua,GAO Xinghua.Research progress on the role of extracellular matrix in liver metastasis of colorectal cancer and targeted therapy[J].Journal Of Pharmaceutical Research,2025,44(7):703-710[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2094times   Download 778次 QR Code for this article
Scan with your phone!
细胞外基质在结直肠癌肝转移中的作用及靶向治疗研究进展
笪慧娟1,曹秋华2,高兴华2
Font:Larger+|Default|Smaller-
(1.中国药科大学多靶标天然药物全国重点实验室,江苏 南京 211198;2.中国药科大学基础医学与临床药学学院,江苏 南京 211198)
摘要:
结直肠癌(colorectal cancer,CRC)是全球第三大恶性肿瘤,结直肠癌肝转移(colorectal liver metastases,CRLM)是中晚期 CRC 患者死亡的首要原因。细胞外基质(extracellular matrix,ECM)是肿瘤微环境的高度活性成分,其通过信号传导不断影响肿瘤细胞的增殖、迁移、侵袭、免疫逃逸及治疗抵抗等。ECM的异常与失调与CRC肝转移进程及患者治疗反应高度相关。因此,干预ECM形成可能是阻断CRLM发生发展的重要策略。本文聚焦于ECM在CRLM中的作用,并综述靶向ECM治疗CRLM的最新进展,旨在为临床CRLM的预防与综合治疗提供新的研究思路。
关键词:  结直肠癌肝转移  细胞外基质  基质硬度  肿瘤细胞  抗肿瘤治疗
DOI:10.13506/j.cnki.jpr.2025.07.012
基金项目:国家自然科学基金项目(No.82273329、32470989、82304551)
Research progress on the role of extracellular matrix in liver metastasis of colorectal cancer and targeted therapy
DA Huijuan1,CAO Qiuhua2,GAO Xinghua2
(1.State Key Laboratory of Nature Medicines, China Pharmaceutical University, Nanjing 211198, China;2.School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China)
Abstract:
Colorectal cancer (CRC) is the third largest malignant tumor in the world, and colorectal liver metastases (CRLM) are the primary cause of death in patients with middle and advanced CRC. The extracellular matrix (ECM) is a highly active component of the tumor microenvironment, which continuously influences the proliferation, migration, invasion, immune escape and therapeutic resistance of tumor cells through signal transduction. The abnormalities and dysregulation of ECM are highly correlated with the liver metastasis process of CRC and the treatment response of patients. Therefore, intervention in ECM formation may be an important strategy to block the occurrence and development of CRLM. This article focuses on the role of ECM in CRLM, and reviews the latest progress of targeting ECM in the treatment of CRLM, aiming to provide a new research idea for the prevention and comprehensive treatment of CRLM.
Key words:  Colorectal liver metastases  Extracellular matrix  Matrix stiffness  Tumor cells  Anti-tumor therapy
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.